Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting the METTL1/m7G axis as a therapeutic strategy in myeloid leukemia.

Blood·2026
Same author

Shenling Baizhu San Ameliorates MASH and Associated Depression-like Behavior in Mice by Impacting Gut Microbiota and Carbohydrate Enzymes.

Combinatorial chemistry & high throughput screening·2026
Same author

Evidence map for randomized controlled trials of treatment of acupuncture and moxibustion for dry eye disease.

Frontiers in medicine·2026
Same author

Measurement properties of patient-reported outcome measures for colorectal cancer: a systematic review.

Frontiers in oncology·2026
Same author

Point-of-care detection of tetanus toxin based on a four-electrode dual-signal immunosensor with non-regenerative and synchronous tracking of co-biomarkers.

Talanta·2026
Same author

CBX6 and CA9 as predictive indicators and therapeutic targets in GBM.

Molecular therapy. Oncology·2026

Related Experiment Video

Updated: Jun 25, 2026

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
07:00

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene

Published on: April 1, 2019

Molecular characterization of aromatase.

Yanyan Hong1, Hongzhi Li, Yate-Ching Yuan

  • 1Department of Surgical Research, Beckman Research Institute of City of Hope, Duarte, California 91010, USA.

Annals of the New York Academy of Sciences
|March 3, 2009
PubMed
Summary

Aromatase, an enzyme crucial for estrogen synthesis, plays a role in breast tumor growth. Understanding its structure and function is key to developing effective aromatase inhibitors for cancer therapy.

More Related Videos

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
10:36

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

Published on: March 17, 2016

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
16:24

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Published on: February 21, 2014

Related Experiment Videos

Last Updated: Jun 25, 2026

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
07:00

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene

Published on: April 1, 2019

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
10:36

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

Published on: March 17, 2016

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
16:24

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Published on: February 21, 2014

Area of Science:

  • Biochemistry
  • Enzymology
  • Cancer Biology

Background:

  • Aromatase is a key enzyme in estrogen synthesis, a process vital for the development and growth of estrogen-dependent breast tumors.
  • Aromatase inhibitors are a promising therapeutic strategy for treating breast cancer.
  • Aromatase is a member of the cytochrome P450 family and interacts with NADPH-cytochrome P450 reductase.

Purpose of the Study:

  • To review the current knowledge on the structural and functional characteristics of aromatase.
  • To address the unsolved questions regarding aromatase's 3D structure, its interaction with reductase, its catalytic mechanism, and inhibitor binding.

Main Methods:

  • This is a review article, synthesizing existing research and knowledge.
  • Focuses on structural and functional aspects of aromatase.

Main Results:

  • No crystal structure of aromatase has been reported due to its membrane-bound nature and heme-binding instability.
  • Significant gaps remain in understanding aromatase's 3D structure, enzyme-substrate interactions, catalytic mechanisms, and inhibitor binding.

Conclusions:

  • Further research into aromatase's structure-function relationship is essential for advancing breast cancer treatment.
  • Addressing the current knowledge gaps will facilitate the design of more potent and specific aromatase inhibitors.